Health Care·Health Care Equipment·$32.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.43 | N/A | +5.56% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $2.43 | N/A | +5.56% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the earnings performance, particularly the EPS beat. They emphasized ongoing commitment to innovation.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and meeting customer needs.
ResMed's earnings report shows a solid EPS performance, which contributed to a positive stock reaction, rising 1.89%. The company did not provide revenue figures or future guidance, leaving investors to focus on the EPS beat as a sign of strength. Management's comments suggest a focus on innovation and customer satisfaction moving forward.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SOFI TECHNOLOGIES IN
Jan 27, 2025